Craif (Location: Bunkyo-ku, Tokyo, CEO: Ryuichi Onose, hereinafter referred to as “Craif”) received the Young Investigator Award at the 60th Annual Meeting of Japan Society of Clinical Oncology (JSCO) on 22nd October, 2022 for a joint research results on esophageal cancer using urinary exosomal miRNA. This study was led by Dr. Kazuhiko Hisaoka, Assistant Professor Satoru Matsuda, and Professor Yuko Kitagawa (Department of Surgery, School of Medicine, Keio University), and Craif provided measurement and analysis support to Keio University. 

Craif will continue to strengthen its partnerships with medical institutions nationwide, and will widely deliver new approaches for early detection and optimization of treatment of various diseases to people, thereby realizing our mission “To Ensure Lifelong Health for Everyone.”